МАБТЕРА
Country: Belarus
Language: Russian
Source: Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)
Summary of Product characteristics
(SPC)
15-08-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Ритуксимаб
Available from:
F.Hoffmann-La Roche Ltd, Швейцария
INN (International Name):
Rituximab
Class:
оригинальное
Prescription type:
по рецепту
Manufactured by:
Genentech Inc., США/ F.Hoffmann-La Roche Ltd, Швейцария/ Roche Diagnostics GmbH, Германия
Therapeutic area:
Ритуксимаб
Product summary:
Нормативная документация: НД РБ 9073-2016; Номер разрешения НД: 10930
Authorization date:
2016-03-02
